Add 2 mL of bacteriostatic water: 5 mg 2 mL = 2.5 mg/mL
For example, in clinical trials of semaglutide 2.4 mg (Wegovy), nausea occurred in approximately 44% of patients, while rates for tirzepatide and other GLP-1s vary: Nausea : Often described as mild queasiness, particularly after eating, though some patients experience more pronounced nausea Bloating and abdominal fullness : A sensation of delayed digestion or food sitting heavily in the stomach Changes in bowel habits : Constipation affects approximately 15-30% of patients (varying by medication and dose), while some experience diarrhea or alternating patterns [1] [4] Decreased appetite : Beyond simple fullness, many report a fundamental shift in food thoughts, with reduced cravings and less mental preoccupation with eating Some patients report fatigue or low energy , particularly during the initial weeks
2019;181:R173R183
Workers compensation billing for 96372 adds another documentation layer
These symptoms are consistent with the drugs mechanism of action, which slows gastric emptying to regulate blood sugar and reduce appetite
To study the effect of monosodium glutamate on histomorphometry of cortex of kidney in adult albino rats
